The global Atrial Septal Defect (ASD) Market was valued at USD 2.4 Billion in 2022. It is projected to reach USD 4.7 Billion by 2032, with a compound annual growth rate (CAGR) of 8.6% during the forecast period. The key drivers of market growth include the increasing prevalence of congenital heart defects (CHD), advancements in minimally invasive treatments, and rising demand for ASD closure devices.
@ https://www.reportsanddata.com..../report-detail/atria
Like
Comment
Share
